68 and FX2149 Attenuate Mutant LRRK2-R1441C-Induced Neural Transport Impairment.

Thomas, Joseph M; Li, Tianxia; Yang, Wei; Xue, Fengtian; Fishman, Paul S; Smith, Wanli W

Thomas, Joseph M; Li, Tianxia; Yang, Wei; Xue, Fengtian; Fishman, Paul S; Smith, Wanli W.

Afiliación

Thomas JM; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy Baltimore, MD, USA.
Li T; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy Baltimore, MD, USA.
Yang W; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy Baltimore, MD, USA.
Xue F; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy Baltimore, MD, USA.
Fishman PS; Department of Neurology, University of Maryland School of MedicineBaltimore, MD, USA; Neurology Service, VA Maryland Healthcare SystemBaltimore, MD, USA.
Smith WW; Department of Psychiatry, Johns Hopkins University School of Medicine Baltimore, MD, USA.

Front Aging Neurosci ; 8: 337, 2016.

Article en En | MEDLINE | ID: mdl-28119604

Palabras clave

GTP binding inhibitor; LRRK2; Parkinson's disease; lysosomes; mitochondria; neural transport

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Aging Neurosci Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google